InGell Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

InGell General Information

Description

Manufacturer of polymer-based injectable hydrogels intended for drug delivery. The company's custom-engineered injectable drug depots are created using water-borne, bioabsorbable polymers which can be mixed with drug compounds or other therapeutic compounds, providing the optimal release profile for the active pharmaceutical ingredient being used.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • L.J. Zielstraweg 1
  • 9713 GX Groningen
  • Netherlands
Primary Industry
Drug Delivery
Vertical(s)
Corporate Office
  • L.J. Zielstraweg 1
  • 9713 GX Groningen
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InGell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Dec-2017 Completed Generating Revenue
2. Corporate 01-Jan-2015 Completed Generating Revenue
1. Early Stage VC 01-Jan-2010 Completed Generating Revenue
To view InGell’s complete valuation and funding history, request access »

InGell Patents

InGell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016349415-A1 Compositions comprising triblock copolymers Active 04-Nov-2015
AU-2016349415-B2 Compositions comprising triblock copolymers Active 04-Nov-2015
CA-3003768-A1 Compositions comprising triblock copolymers Active 04-Nov-2015
EP-3370789-A1 Compositions comprising triblock copolymers Active 04-Nov-2015
EP-3370789-B1 Compositions comprising triblock copolymers Active 04-Nov-2015 C08L71/02
To view InGell’s complete patent history, request access »

InGell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InGell Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Branching Tree Venture Capital Minority
GJ Smid Fonds Venture Capital Minority
PolyVation Corporation Minority
RUG Ventures Venture Capital Minority
To view InGell’s complete investors history, request access »

InGell FAQs

  • When was InGell founded?

    InGell was founded in 2010.

  • Where is InGell headquartered?

    InGell is headquartered in Groningen, Netherlands.

  • What is the size of InGell?

    InGell has 5 total employees.

  • What industry is InGell in?

    InGell’s primary industry is Drug Delivery.

  • Is InGell a private or public company?

    InGell is a Private company.

  • What is InGell’s current revenue?

    The current revenue for InGell is .

  • Who are InGell’s investors?

    Branching Tree, GJ Smid Fonds, PolyVation, and RUG Ventures have invested in InGell.

  • When was InGell acquired?

    InGell was acquired on 01-Dec-2017.

  • Who acquired InGell?

    InGell was acquired by InnoCore Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process